Skip to content

Drug interactions

Dimenhydrinate + OnabotulinumtoxinA

Severity: Minor

Dimenhydrinate and OnabotulinumtoxinA: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Anticholinergic drugs may theoretically add to the effects of botulinum toxin on cholinergic transmission. This could increase systemic anticholinergic effects, though the clinical significance with dimenhydrinate is uncertain.

What this interaction means in plain words

Dimenhydrinate and OnabotulinumtoxinA have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dimenhydrinate belongs to Respiratory; OnabotulinumtoxinA belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Theoretical additive reduction of cholinergic transmission (antimuscarinic effect plus blockade of acetylcholine release).

What to do

No empirical dose change is needed. Monitor for generalized weakness, swallowing or breathing difficulty, and anticholinergic symptoms after injection.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dimenhydrinate and OnabotulinumtoxinA, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dimenhydrinate with OnabotulinumtoxinA?

MediHelp rates the interaction as minor. Dimenhydrinate and OnabotulinumtoxinA have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Anticholinergic drugs may theoretically add to the effects of botulinum toxin on cholinergic transmission. This could increase systemic anticholinergic effects, though the clinical significance with dimenhydrinate is uncertain.

How serious is the interaction between Dimenhydrinate and OnabotulinumtoxinA?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empirical dose change is needed. Monitor for generalized weakness, swallowing or breathing difficulty, and anticholinergic symptoms after injection.

What other medicines interact with Dimenhydrinate?

MediHelp also lists interactions of Dimenhydrinate with, for example, Belladonna and opium, Brexanolone, Calcium / magnesium / potassium / sodium oxybates. The full list is on the Dimenhydrinate page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in